Dr. Saro Ochoa, an Italian physician based in Ecuador for two decades, shares her vision on the value of non-invasive neuromodulation within a comprehensive approach to complex patients, especially those with chronic pain, central hypersensitization syndromes, fibromyalgia and dual pathology associated with anxiety, depression or psychotropic drug dependence. In her testimony, she explains that her clinical practice is based on a global view of the patient, understanding that it is not possible to separate the physical from the emotional dimension, nor to treat symptoms in isolation when there is a sustained alteration of the nervous system.
As she relates, the interest in NESA arose from seeking a tool that would allow expanding the neuromodulation work they already performed, incorporating not only the peripheral nervous system, but also a more central and integrative action. For her, this technology represents particularly valuable support in patients who arrive after having gone through multiple treatments without achieving sufficient improvement. She also emphasizes that, in this type of condition, insomnia, anxiety and poor regulation of the autonomic nervous system deeply condition the evolution of pain and other symptoms.
Dr. Saro Ochoa emphasizes that NESA does not replace other interventions, but integrates with physiotherapy, psychology and psychonutrition within an interdisciplinary model. In her view, the improvement of natural rest, the modulation of the nervous system and the joint work between professionals are key to offering a more effective and humane response to patients with complex and long-evolution pathologies.
